|
1
|
Gossage L, Eisen T and Maher ER: VHL, the
story of a tumour suppressor gene. Nat Rev Cancer. 15:55–64. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Neumann HP and Wiestler OD: Clustering of
features of von Hippel-Lindau syndrome: Evidence for a complex
genetic locus. Lancet. 337:1052–1054. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maher ER, Yates JR, Harries R, Benjamin C,
Harris R, Moore AT and Ferguson-Smith MA: Clinical features and
natural history of von Hippel-Lindau disease. Q J Med.
77:1151–1163. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maher ER, Neumann HP and Richard S: von
Hippel-Lindau disease: A clinical and scientific review. Eur J Hum
Genet. 19:617–623. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bader HL and Hsu T: Systemic VHL gene
functions and the VHL disease. FEBS Lett. 586:1562–1569. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nielsen SM, Rhodes L, Blanco I, Chung WK,
Eng C, Maher ER, Richard S and Giles RH: Von Hippel-Lindau disease:
Genetics and role of genetic counseling in a multiple neoplasia
syndrome. J Clin Oncol. 34:2172–2181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nordstrom-O'Brien M, van der Luijt RB, van
Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van
Brussel A, Voest EE and Giles RH: Genetic analysis of von
Hippel-Lindau disease. Hum Mutat. 31:521–537. 2010.PubMed/NCBI
|
|
8
|
Chen F, Kishida T, Yao M, Hustad T, Glavac
D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, et al: Germline
mutations in the von Hippel-Lindau disease tumor suppressor gene:
Correlations with phenotype. Hum Mutat. 5:66–75. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M
and Kaelin WG Jr: von Hippel-Lindau protein mutants linked to type
2C VHL disease preserve the ability to downregulate HIF. Hum Mol
Genet. 10:1019–1027. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Richard S, David P, Marsot-Dupuch K,
Giraud S, Béroud C and Resche F: Central nervous system
hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau
disease. Neurosurg Rev. 23:1–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang JY, Peng SH, Li T, Ning XH, Liu SJ,
Hong BA, Liu JY, Wu PJ, Zhou BW, Zhou JC, et al: Risk factors for
survival in patients with von Hippel-Lindau disease. J Med Genet.
55:322–328. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu P, Zhang N, Wang X, Ning X, Li T, Bu D
and Gong K: Family history of von Hippel-Lindau disease was
uncommon in Chinese patients: Suggesting the higher frequency of de
novo mutations in VHL gene in these patients. J Hum Genet.
57:238–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang JY, Peng SH, Ning XH, Li T, Liu SJ,
Liu JY, Hong BA, Qi NN, Peng X, Zhou BW, et al: Shorter telomere
length increases age-related tumor risks in von Hippel-Lindau
disease patients. Cancer Med. 6:2131–2141. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital organs-part a: Renal, penile, and
testicular tumours. Eur Urol. 70:93–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim SP, Alt AL, Weight CJ, Costello BA,
Cheville JC, Lohse C, Allmer C and Leibovich BC: Independent
validation of the 2010 American Joint Committee on Cancer TNM
classification for renal cell carcinoma: Results from a large,
single institution cohort. J Urol. 185:2035–2039. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ning XH, Li T, Gong YQ, He Q, Shen QI,
Peng SH, Wang JY, Chen JC, Guo YL and Gong K: Association between
FBP1 and hypoxia-related gene expression in clear cell renal cell
carcinoma. Oncol Lett. 11:4095–4098. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Neumann HP, Bender BU, Berger DP,
Laubenberger J, Schultze-Seemann W, Wetterauer U, Ferstl FJ, Herbst
EW, Schwarzkopf G, Hes FJ, et al: Prevalence, morphology and
biology of renal cell carcinoma in von Hippel-Lindau disease
compared to sporadic renal cell carcinoma. J Urol. 160:1248–1254.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choyke PL, Glenn GM, Walther MM, Patronas
NJ, Linehan WM and Zbar B: Von Hippel-Lindau disease: Genetic,
clinical, and imaging features. Radiology. 194:629–642. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ning XH, Zhang N, Li T, Wu PJ, Wang X, Li
XY, Peng SH, Wang JY, Chen JC and Gong K: Telomere shortening is
associated with genetic anticipation in Chinese Von Hippel-Lindau
disease families. Cancer Res. 74:3802–3809. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Walther MM, Lubensky IA, Venzon D, Zbar B
and Linehan WM: Prevalence of microscopic lesions in grossly normal
renal parenchyma from patients with von Hippel-Lindau disease,
sporadic renal cell carcinoma and no renal disease: Clinical
implications. J Urol. 154:2010–2015. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Binderup ML, Jensen AM, Budtz-Jørgensen E
and Bisgaard ML: Survival and causes of death in patients with von
Hippel-Lindau disease. J Med Genet. 54:11–18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duffey BG, Choyke PL, Glenn G, Grubb RL,
Venzon D, Linehan WM and Walther MM: The relationship between renal
tumor size and metastases in patients with von Hippel-Lindau
disease. J Urol. 172:63–65. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gupta GN, Peterson J, Thakore KN, Pinto
PA, Linehan WM and Bratslavsky G: Oncological outcomes of partial
nephrectomy for multifocal renal cell carcinoma greater than 4 cm.
J Urol. 184:59–63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lonser RR, Glenn GM, Walther M, Chew EY,
Libutti SK, Linehan WM and Oldfield EH: Von Hippel-Lindau disease.
Lancet. 361:2059–2067. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Crespigio J, Berbel L, Dias MA, Berbel RF,
Pereira SS, Pignatelli D and Mazzuco TL: Von Hippel-Lindau disease:
A single gene, several hereditary tumors. J Endocrinol Invest.
41:21–31. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rao P, Monzon F, Jonasch E, Matin SF and
Tamboli P: Clear cell papillary renal cell carcinoma in patients
with von Hippel-Lindau syndrome-clinicopathological features and
comparative genomic analysis of 3 cases. Hum Pathol. 45:1966–1972.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Diolombi ML, Cheng L, Argani P and Epstein
JI: Do clear cell papillary renal cell carcinomas have malignant
potential. Am J Surg Pathol. 39:1621–1634. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim E and Zschiedrich S: Renal cell
carcinoma in von Hippel-Lindau disease-from tumor genetics to novel
therapeutic strategies. Front Pediatr. 6:162018. View Article : Google Scholar : PubMed/NCBI
|
